Literature DB >> 35246662

Towards a deeper understanding of the vaginal microbiota.

Michael France1,2, Madeline Alizadeh1,2, Sarah Brown1,3, Bing Ma1,2, Jacques Ravel4,5.   

Abstract

The human vaginal microbiota is a critical determinant of vaginal health. These communities live in close association with the vaginal epithelium and rely on host tissues for resources. Although often dominated by lactobacilli, the vaginal microbiota is also frequently composed of a collection of facultative and obligate anaerobes. The prevalence of these communities with a paucity of Lactobacillus species varies among women, and epidemiological studies have associated them with an increased risk of adverse health outcomes. The mechanisms that drive these associations have yet to be described in detail, with few studies establishing causative relationships. Here, we review our current understanding of the vaginal microbiota and its connection with host health. We centre our discussion around the biology of the vaginal microbiota when Lactobacillus species are dominant versus when they are not, including host factors that are implicated in shaping these microbial communities and the resulting adverse health outcomes. We discuss current approaches to modulate the vaginal microbiota, including probiotics and vaginal microbiome transplants, and argue that new model systems of the cervicovaginal environment that incorporate the vaginal microbiota are needed to progress from association to mechanism and this will prove invaluable for future research.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35246662      PMCID: PMC8910585          DOI: 10.1038/s41564-022-01083-2

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   30.964


  206 in total

1.  Is There a Protective Role for Vaginal Flora?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Vaginal microbiome of reproductive-age women.

Authors:  Jacques Ravel; Pawel Gajer; Zaid Abdo; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Reshma Gorle; Jennifer Russell; Carol O Tacket; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Ligia Peralta; Larry J Forney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

Review 3.  Vaginal microbiome: rethinking health and disease.

Authors:  Bing Ma; Larry J Forney; Jacques Ravel
Journal:  Annu Rev Microbiol       Date:  2012-06-28       Impact factor: 15.500

4.  Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.

Authors:  E R Boskey; K M Telsch; K J Whaley; T R Moench; R A Cone
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species.

Authors:  M A Antonio; S E Hawes; S L Hillier
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women.

Authors:  S L Hillier; M A Krohn; L K Rabe; S J Klebanoff; D A Eschenbach
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

7.  Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods.

Authors:  Xia Zhou; Stephen J Bent; Maria G Schneider; Catherine C Davis; Mohammed R Islam; Larry J Forney
Journal:  Microbiology (Reading)       Date:  2004-08       Impact factor: 2.777

Review 8.  Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis.

Authors:  Muriel Aldunate; Daniela Srbinovski; Anna C Hearps; Catherine F Latham; Paul A Ramsland; Raffi Gugasyan; Richard A Cone; Gilda Tachedjian
Journal:  Front Physiol       Date:  2015-06-02       Impact factor: 4.566

9.  Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.

Authors:  David J Delgado-Diaz; David Tyssen; Joshua A Hayward; Raffi Gugasyan; Anna C Hearps; Gilda Tachedjian
Journal:  Front Cell Infect Microbiol       Date:  2020-01-10       Impact factor: 5.293

10.  Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.

Authors:  Deirdre E O'Hanlon; Thomas R Moench; Richard A Cone
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more
  5 in total

1.  Can Bacteriophages Replace Antibiotics?

Authors:  Mikael Skurnik
Journal:  Antibiotics (Basel)       Date:  2022-04-26

2.  Disturbances of Vaginal Microbiome Composition in Human Papillomavirus Infection and Cervical Carcinogenesis: A Qualitative Systematic Review.

Authors:  Ming Wu; Huanrong Li; Hongfei Yu; Ye Yan; Chen Wang; Fei Teng; Aiping Fan; Fengxia Xue
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

3.  Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report.

Authors:  Ilkay Başak Uysal; Vanina Boué; Carmen Lia Murall; Christelle Graf; Christian Selinger; Christophe Hirtz; Claire Bernat; Jacques Ravel; Jacques Reynes; Marine Bonneau; Massilva Rahmoun; Michel Segondy; Nathalie Boulle; Sophie Grasset; Soraya Groc; Tim Waterboer; Vincent Tribout; Ignacio G Bravo; Sonia Burrel; Vincent Foulongne; Samuel Alizon; Nicolas Tessandier
Journal:  IDCases       Date:  2022-08-19

4.  Complete Genome Sequences of Ezakiella coagulans C0061C1 and Fenollaria massiliensis C0061C2.

Authors:  Michael T France; Jack Clifford; Shilpa Narina; Lindsay Rutt; Jacques Ravel
Journal:  Microbiol Resour Announc       Date:  2022-07-05

Review 5.  Cervicovaginal Microbiota Composition in Chlamydia trachomatis Infection: A Systematic Review and Meta-Analysis.

Authors:  Marisa Di Pietro; Simone Filardo; Ilaria Simonelli; Patrizio Pasqualetti; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.